Paper38020385
Data-driven discovery of innate immunomodulators via machine learning-guided high throughput screening.
Tang Y and 7 others. Chem Sci, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Data-driven discovery of innate immunomodulators via machine learning-guided high throughput screening. Papers, record 38020385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38020385
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Data-driven discovery of innate immunomodulators via machine learning-guided high throughput screening.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 75N93019C00041 | NIAID NIH HHS | United States | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7782278 | Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7782278 | PubMed |
| 2 | 30483250 | Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation. | Front Immunol | 2018 | https://conductscience.org/library/papers/30483250 | PubMed |
| 3 | 29995272 | Molecular generative model based on conditional variational autoencoder for de novo molecular design. | J Cheminform | 2018 | https://conductscience.org/library/papers/29995272 | PubMed |
| 4 | 15667143 | ZINC--a free database of commercially available compounds for virtual screening. | J Chem Inf Model | 2005 | https://conductscience.org/library/papers/15667143 | PubMed |
| 5 | 17569868 | The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. | Science | 2007 | https://conductscience.org/library/papers/17569868 | PubMed |
| 6 | 33052748 | Small molecule agonists of toll-like receptors 7 and 8: a patent review 2014 - 2020. | Expert Opin Ther Pat | 2020 | https://conductscience.org/library/papers/33052748 | PubMed |
| 7 | 24351051 | QSAR modeling: where have you been? Where are you going to? | J Med Chem | 2014 | https://conductscience.org/library/papers/24351051 | PubMed |
| 8 | 34692565 | Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34692565 | PubMed |
| 9 | 32180410 | Discovery of Self-Assembling π-Conjugated Peptides by Active Learning-Directed Coarse-Grained Molecular Simulation. | J Phys Chem B | 2020 | https://conductscience.org/library/papers/32180410 | PubMed |
| 10 | 26479676 | ZINC 15--Ligand Discovery for Everyone. | J Chem Inf Model | 2015 | https://conductscience.org/library/papers/26479676 | PubMed |
| 11 | 26384394 | A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation. | J Biomol Screen | 2015 | https://conductscience.org/library/papers/26384394 | PubMed |
| 12 | 16932750 | IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16932750 | PubMed |
| 13 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 14 | 28604160 | Use of adjuvants for immunotherapy. | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/28604160 | PubMed |
| 15 | 32917696 | Increased vaccine tolerability and protection via NF-κB modulation. | Sci Adv | 2020 | https://conductscience.org/library/papers/32917696 | PubMed |
| 16 | 36968540 | Discovery of New States of Immunomodulation for Vaccine Adjuvants via High Throughput Screening: Expanding Innate Responses to PRRs. | ACS Cent Sci | 2023 | https://conductscience.org/library/papers/36968540 | PubMed |
| 17 | 33824489 | Emerging concepts in the science of vaccine adjuvants. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33824489 | PubMed |
| 18 | 31906991 | Toll-like receptor 4 agonist and antagonist lipopolysaccharides modify innate immune response in rat brain circumventricular organs. | J Neuroinflammation | 2020 | https://conductscience.org/library/papers/31906991 | PubMed |
| 19 | 33118813 | ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery. | J Chem Inf Model | 2020 | https://conductscience.org/library/papers/33118813 | PubMed |
| 20 | 34254518 | A Data-Driven Dimensionality Reduction Approach to Compare and Classify Lipid Force Fields. | J Phys Chem B | 2021 | https://conductscience.org/library/papers/34254518 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948775 | Liuwei Kangguan Formula: Mechanism-driven and computation-assisted optimization from Xuanfei Baidu Formula for combating SARS-CoV-2 infection. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/42948775 | PubMed |
| 42924606 | Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42924606 | PubMed |
| 42635620 | Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42635620 | PubMed |
| 42023232 | Interferon regulatory factors: the next prospective targets for tissue ischemia-reperfusion injury? | Front Immunol | 2026 | https://conductscience.org/library/papers/42023232 | PubMed |
| 41144841 | VDLIN: A Deep Learning-Based Platform for Methylcobalamin-Inspired Immunomodulatory Compound Screening. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41144841 | PubMed |
| 40699210 | Bioengineering approaches to trained immunity: Physiologic targets and therapeutic strategies. | Elife | 2025 | https://conductscience.org/library/papers/40699210 | PubMed |
| 40051535 | The Promise and Predicament of Combining Adjuvants in Vaccines. | Vaccine Insights | 2025 | https://conductscience.org/library/papers/40051535 | PubMed |
| 38913893 | Machine learning in biological physics: From biomolecular prediction to design. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38913893 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNB1 | 3456 | PubTator's text mining | https://conductscience.org/library/genes/3456 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38020385
GET https://conductscience.org/api/papers/v1/38020385/references?page=2